Podatki
-
Stitch Fix (SFIX) Posts Q2 Loss of $0.02/Share, Revenue Rises 9%
Stitch Fix reports Q2 fiscal 2026 loss of $0.02 per share on revenue of $337.5M, up 3.8% year-over-year, with adjusted EBITDA turning positive at $11.5M. The post Stitch Fix (SFIX) Posts Q2 Loss of $0.02/Share, Revenue Rises 9% first appeared on Alphastreet.
AlphaStreet
2026-03-12, 13:13
-
Viant Technology (DSP) Q4 Revenue Surges 22.3% to $110.1M Despite Flat EPS at $0.22
Viant Technology Q4 adjusted EPS of $0.22 matched year-ago levels as revenue surged 22.3% to $110.1M, capping a year of accelerating growth. The post Viant Technology (DSP) Q4 Revenue Surges 22.3% to $110.1M Despite Flat EPS at $0.22 first appeared on Alphastreet.
AlphaStreet
2026-03-12, 13:20
-
Viant Technology (DSP) Reports Q4 Adjusted EPS of $0.22, Revenue Surges 22% to $110.1M
Viant Technology posts $0.22 adjusted EPS in Q4, matching prior quarter, as revenue climbs 22% year-over-year to $110.1M. The post Viant Technology (DSP) Reports Q4 Adjusted EPS of $0.22, Revenue Surges 22% to $110.1M first appeared on Alphastreet.
AlphaStreet
2026-03-12, 13:21
-
Biote (BTMD) Q4 Earnings Plunge 84% YoY to $0.06 Despite Flat Revenue
Biote's Q4 EPS of $0.06 matched the prior quarter but plunged 83.8% year-over-year as profitability collapsed despite flat revenue. The post Biote (BTMD) Q4 Earnings Plunge 84% YoY to $0.06 Despite Flat Revenue first appeared on Alphastreet.
AlphaStreet
2026-03-12, 13:30
-
Stitch Fix (SFIX) Q2 Earnings: $0.02 Loss Meets Estimates as Revenue Stabilizes at $341.3M
Stitch Fix posts Q2 loss of $0.02 per share, matching estimates, as revenue of $337.5M holds flat while year-over-year comparisons turn positive for the first time in recent quarters. The post Stitch Fix (SFIX) Q2 Earnings: $0.02 Loss Meets Estimates as Revenue Stabilizes at $341.3M first appeared on Alphastreet.
AlphaStreet
2026-03-12, 12:40
-
Flotek (FTK) Earnings Plunge 55% Despite 33% Revenue Jump to $67.5M on Margin Pressure
Flotek posts $0.08 EPS on 33% revenue growth to $67.5M, but earnings fall 55% year-over-year as margins compress despite strong top-line momentum. The post Flotek (FTK) Earnings Plunge 55% Despite 33% Revenue Jump to $67.5M on Margin Pressure first appeared on Alphastreet.
AlphaStreet
2026-03-12, 12:48
-
NBIS Stock Jumps 14.4% to $110.32 on Heavy Volume
NBIS shares surged 14.4% to $110.32 on volume 2.27x average, though no specific catalyst was identified in available data. The post NBIS Stock Jumps 14.4% to $110.32 on Heavy Volume first appeared on Alphastreet.
AlphaStreet
2026-03-11, 21:38
-
DigitalOcean (DOCN) Stock Surges 9.72% to $68.04 on Heavy Volume
DOCN shares jump 9.72% to $68.04 on 18% above-average volume with no confirmed catalyst identified in available data. The post DigitalOcean (DOCN) Stock Surges 9.72% to $68.04 on Heavy Volume first appeared on Alphastreet.
AlphaStreet
2026-03-11, 21:05
-
HMY Stock Drop 12.8% Today Amid Gold Mining Sector Selloff
HMY shares fell 12.8% to $16.52 on elevated volume with no company-specific catalyst, reflecting sector-wide weakness in gold mining equities. The post HMY Stock Drop 12.8% Today Amid Gold Mining Sector Selloff first appeared on Alphastreet.
AlphaStreet
2026-03-11, 21:17
-
UNFI Stock Surges 9.9% to $41.41 as Three Consecutive Earnings Beats Draw Investor Attention
UNFI shares jumped 9.9% to $41.41 with no clear catalyst, though three straight quarters of earnings beats may be drawing renewed investor interest. The post UNFI Stock Surges 9.9% to $41.41 as Three Consecutive Earnings Beats Draw Investor Attention first appeared on Alphastreet.
AlphaStreet
2026-03-11, 20:49
-
Verrica (VRCA) Q4 Loss Narrows Sharply to $0.51/Share as Revenue Surges to $5.1M
Verrica narrows Q4 loss 72% year-over-year to -$0.51 per share as revenue surges 1,383% to $5.1M, though sequential revenue drops 65% from Q3. The post Verrica (VRCA) Q4 Loss Narrows Sharply to $0.51/Share as Revenue Surges to $5.1M first appeared on Alphastreet.
AlphaStreet
2026-03-11, 20:18
-
Navitas Semiconductor (NVTS) Q4 Loss Narrows to $0.05/Share, Shares Surge 23%
Navitas Semiconductor posts narrower-than-expected Q4 loss of $0.05/share; shares surge 23% despite ongoing cash burn and revenue pressure. The post Navitas Semiconductor (NVTS) Q4 Loss Narrows to $0.05/Share, Shares Surge 23% first appeared on Alphastreet.
AlphaStreet
2026-03-11, 19:34
-
AXTI Stock Jumps 7.4% to $47.59 on Heavy Volume
AXTI shares jumped 7.4% to $47.59 with no confirmed catalyst, as volume ran 16% above average following a sequential revenue recovery in Q4. The post AXTI Stock Jumps 7.4% to $47.59 on Heavy Volume first appeared on Alphastreet.
AlphaStreet
2026-03-11, 19:57
-
CNC Stock Plunges 16% on ACA Enrollment Cliff Concerns Impacting Profitability
CNC shares plunge 16% as investor concerns about ACA enrollment cliff impact on profitability trigger broad-based selling. The post CNC Stock Plunges 16% on ACA Enrollment Cliff Concerns Impacting Profitability first appeared on Alphastreet.
AlphaStreet
2026-03-11, 19:02
-
Minerva Neurosciences, Inc (NERV) Reports Q4 Earnings
**Minerva Neurosciences Reports Q4 2025 Results** The post Minerva Neurosciences, Inc (NERV) Reports Q4 Earnings first appeared on Alphastreet.
AlphaStreet
2026-03-11, 19:10
-
Nio (NIO) Surges 15% After Posting First-Ever Quarterly Profit, Beating EPS Estimates
Nio posts first-ever quarterly profit with Q4 EPS of $0.29 vs $0.05 estimate; shares surge 15% on delivery growth and margin expansion. The post Nio (NIO) Surges 15% After Posting First-Ever Quarterly Profit, Beating EPS Estimates first appeared on Alphastreet.
AlphaStreet
2026-03-11, 19:27
-
Figure Technology (FIGR) Shares Surge 21% Despite Missing Q4 EPS
Figure Technology Solutions missed Q4 EPS estimates by 36% yet shares surged 21% on sequential revenue growth and undisclosed forward catalysts. The post Figure Technology (FIGR) Shares Surge 21% Despite Missing Q4 EPS first appeared on Alphastreet.
AlphaStreet
2026-03-11, 18:38
-
BioNTech (BNTX) Reports Q4 Loss of EUR0.33/Share as COVID Vaccine Revenue Plunges; Founders Exit
BioNTech posts wider-than-expected Q4 loss of $0.33/share as COVID vaccine revenue plunges 24% year-over-year; founders to exit for new mRNA venture. The post BioNTech (BNTX) Reports Q4 Loss of EUR0.33/Share as COVID Vaccine Revenue Plunges; Founders Exit first appeared on Alphastreet.
AlphaStreet
2026-03-11, 18:03
-
Dyne Therapeutics (DYN) Q4 Loss Narrows to $0.73/Share vs $0.76 Estimate, Shares Surge 11.8%
Dyne Therapeutics narrows Q4 loss to $0.73/share vs $0.76 estimate, shares jump 11.8% on improving trajectory and $893M cash position. The post Dyne Therapeutics (DYN) Q4 Loss Narrows to $0.73/Share vs $0.76 Estimate, Shares Surge 11.8% first appeared on Alphastreet.
AlphaStreet
2026-03-11, 18:21
-
HPE Maintains $0.14 Quarterly Dividend With 2.61% Yield; Ex-Dividend Date March 24, 2026
HPE maintains its $0.14 quarterly dividend with a 2.7% yield; ex-date March 24, 2026. The post HPE Maintains $0.14 Quarterly Dividend With 2.61% Yield; Ex-Dividend Date March 24, 2026 first appeared on Alphastreet.
AlphaStreet
2026-03-11, 16:35
-
Broadwind Energy Inc (BWEN) Reports Q4 Earnings
**Broadwind Energy Inc Reports Q4 2025 Results** The post Broadwind Energy Inc (BWEN) Reports Q4 Earnings first appeared on Alphastreet.
AlphaStreet
2026-03-11, 16:02
-
Sprinklr Inc (CXM) Beats Q4 FY26 EPS Estimates
Sprinklr Inc (CXM) delivered Q4 2025 adjusted earnings of $0.10 per share, surpassing analysts' $0.09 forecast (beat by 10.0%). Top-line revenue was $219.1... The post Sprinklr Inc (CXM) Beats Q4 FY26 EPS Estimates first appeared on Alphastreet.
AlphaStreet
2026-03-11, 16:16
-
ATRenew Inc (RERE) Reports Q4 Earnings
**ATRenew Inc Reports Q4 2025 Results** The post ATRenew Inc (RERE) Reports Q4 Earnings first appeared on Alphastreet.
AlphaStreet
2026-03-11, 15:43
-
Cadre Holdings, Inc. (CDRE) Misses Q4 EPS Estimates
**Cadre Holdings Reports Q4 2025 Earnings Miss** The post Cadre Holdings, Inc. (CDRE) Misses Q4 EPS Estimates first appeared on Alphastreet.
AlphaStreet
2026-03-11, 15:06
-
CRISPR Therapeutics (CRSP) Reports Wider Q4 Loss of $1.37/Share on Zero Revenue; Shares Plunge 10%
CRISPR Therapeutics posts wider-than-expected Q4 loss of $1.37/share on zero revenue; shares sink 10% as cash burn accelerates. The post CRISPR Therapeutics (CRSP) Reports Wider Q4 Loss of $1.37/Share on Zero Revenue; Shares Plunge 10% first appeared on Alphastreet.
AlphaStreet
2026-03-11, 15:12